Lv62
2630 积分 2022-09-22 加入
Immunogenic cell death inducers:Current advances and future perspectives
14天前
已完结
Interleukin-2–based therapies in cancer
1个月前
已完结
Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy
1个月前
已完结
Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy
1个月前
已完结
Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy
2个月前
已完结
Discrepant antitumor efficacies of three CpG oligodeoxynucleotide classes in monotherapy and co-therapy with PD-1 blockade
2个月前
已关闭
Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells
3个月前
已完结
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
3个月前
已完结
Tumor-activated IL-2 mRNA delivered by lipid nanoparticles for cancer immunotherapy
3个月前
已完结
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
4个月前
已完结
皖公网安备34019202002308
